{"version":"1.0","provider_name":"Canadian Drug Policy Coalition","provider_url":"https:\/\/www.drugpolicy.ca\/fr\/","author_name":"admin","author_url":"https:\/\/www.drugpolicy.ca\/fr\/author\/admin\/","title":"Three drug policy stories to watch in 2012 - Canadian Drug Policy Coalition","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"ExMlqSdw26\"><a href=\"https:\/\/www.drugpolicy.ca\/fr\/three-drug-policy-stories-to-watch-in-2012\/\">Three drug policy stories to watch in 2012<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.drugpolicy.ca\/fr\/three-drug-policy-stories-to-watch-in-2012\/embed\/#?secret=ExMlqSdw26\" width=\"600\" height=\"338\" title=\"&#8220;Three drug policy stories to watch in 2012&#8221; &#8212; Canadian Drug Policy Coalition\" data-secret=\"ExMlqSdw26\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.drugpolicy.ca\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","thumbnail_url":"https:\/\/www.drugpolicy.ca\/wp-content\/uploads\/2010\/06\/CDPC_Stories2012_Blog_415x415px-S.jpg","thumbnail_width":415,"thumbnail_height":415,"description":"Insite opens the door North America\u2019s only sanctioned safe injection facility was the big news story of 2011. The September 30, 2011 Canadian supreme court decision in favor of the safe injection facility is a crucial victory for evidence-based science and policy over ideology. It is a historic decision for harm reduction advocates that has [&hellip;]"}